GlaxoSmithKline: medicamento parece eficaz contra ómicron
El Reino Unido aprobó el tratamiento de GSK con anticuerpos monoclonales contra el coronavirus
El cóctel sería eficaz contra la variante Ómicron, según afirmó el laboratorio. En los ensayos mostró que reduce en 79% el riesgo de hospitalización y muerte en adultos sintomáticos de alto riesgo
La agencia reguladora europea evalúa si autoriza el uso de un anticuerpo monoclonal contra el COVID-19
Se trata del sotrovimab, del laboratorio GlaxoSmithKline, indicado para adultos y adolescentes que contrajeron la enfermedad y tienen condiciones de riesgo que podrían conducir a un cuadro grave
WADA AND KYOWA KIRIN CO. SIGN AGREEMENT FORMALIZING COLLABORATION TO PROTECT CLEAN SPORT
No IOC Sponsor Movement; Fencing World Champs End; Putin Called a "Bully"
(ATR) The IOC appears unlikely to meet its goal of two new sponsors before the IOC Session… Russia tops fencing world championship medal table… U.S. Senator plots embarrassment for Putin at opening ceremony.
IOC in TOP Sponsor Talks with GSK; Coe Reacts to Doping Scandal
(ATR) GlaxoSmithKline discusses TOP Sponsorship... Sebastian Coe reacts to the ongoing doping scandal... Russian Interior Ministry issues warrant for Bialov... More inside...
Oscar Pistorius and Jonnie Peacock go head to head as season starts at BT Paralympic World Cup
London Latest - Interpol on Terrorism Threat; Doping Crackdown at Olympics
(ATR) Secretary general says police agency has received no specific intelligence that Games will be targeted ... 2012 anti-doping lab unveiled ... Legacy plans for media centers take shape ...
WADA Signs Historic Agreement with Pharma Giant GlaxoSmithKline
Olympic Newsdesk -- WHO to Vancouver; 2011 Mascots; GlaxoSmithKline for 2012
(ATR) World Health Organization to monitor 2010 Games for flu
outbreaks… Pan Am Mascots revealed… GlaxoSmithKline signs with LOCOG
